| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1078726
Max Phase: Preclinical
Molecular Formula: C21H16ClN3O2
Molecular Weight: 377.83
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(Nc1ccccc1Cl)c1cnn2ccc(OCc3ccccc3)cc12
Standard InChI: InChI=1S/C21H16ClN3O2/c22-18-8-4-5-9-19(18)24-21(26)17-13-23-25-11-10-16(12-20(17)25)27-14-15-6-2-1-3-7-15/h1-13H,14H2,(H,24,26)
Standard InChI Key: UYOQRNSCWIITKH-UHFFFAOYSA-N
Associated Targets(Human)
Ephrin type-B receptor 3 1881 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 377.83 | Molecular Weight (Monoisotopic): 377.0931 | AlogP: 4.82 | #Rotatable Bonds: 5 |
| Polar Surface Area: 55.63 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 0.78 | CX LogP: 4.77 | CX LogD: 4.77 |
| Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.54 | Np Likeness Score: -1.68 |
References
| 1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |
Source
Source(1):